Discover 1,005 paid clinical trials in Minneapolis, Minnesota. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Minneapolis currently offers various active clinical trials with a focus on many chronic conditions, including asthma, arthritis, kidney disease, and hidradenitis suppurativa. The city’s leading healthcare institutions are recruiting participants to take part in paid research studies as healthy volunteers, as well as those looking for studies targeting specific health issues, providing access to innovative treatments and contributing to the development of new therapies.
Filter
2
Filter results
Results: 1,005
Active & ResponsiveNew
REMIND Maintenance Radiotherapy for Newly Diagnosed Glioblastoma
Belimumab With Rituximab for Primary Membranous Nephropathy
for
Membranous Nephropathy, Nephrotic Syndrome
Location: Minneapolis MN, Omaha NE, St Louis MO, Ann Arbor MI,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 18 - 70+
Code: NCT03949855
Phase 2, Recruiting
Active & Responsive
Slow Heart Registry of Fetal Immune-mediated High Degree Heart Block
for
Heart Block Complete, Heart Block Second Degree
Location: Minneapolis MN, Milwaukee WI, Kansas City KS, Toronto,
Sponsor: The Hospital for Sick Children
Sex: Female
Age: 16 - 50
Code: NCT04559425
Recruiting
Active & Responsive
Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants
for
Lactating Women on Select DOI,
Location: Minneapolis MN, Chicago IL, Pittsburgh PA, Amarillo TX,
Sponsor: Duke University
Sex: All
Age: 0+
Code: NCT03511118
Recruiting
Active & Responsive
Vorasidenib Study in Pediatric Participants With Grade 2 Astrocytoma or Oligodendroglioma With an IDH1 or IDH2 Mutation
for
Grade 2 Astrocytoma or Oligodendroglioma With an IDH1 or IDH2 Mutation,
Location: Minneapolis MN, Chicago IL, Boston MA, Los Angeles CA
Sponsor: Institut de Recherches Internationales Servier (I.R.I.S.)
Sex: All
Age: 12 - 17
Code: NCT07286292
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II
for
Lymphoblastic Leukemia
Location: Minneapolis MN, Little Rock AR, Hershey PA,
Sponsor: Tanja Andrea Gruber
Sex: All
Age: 0 - 1
Code: NCT05848687
Phase 1, Phase 2, Recruiting
Active & Responsive
Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary Blastoma
Location: Minneapolis MN, Madison WI, Milwaukee WI, Peoria IL,
Sponsor: Medical College of Wisconsin
Sex: Female
Age: 18+
Code: NCT02774746
Recruiting
Active & Responsive
FOG-001 in Locally Advanced or Metastatic Solid Tumors
for
Cancer, Colorectal Cancer, Solid Tumor,
Location: Minneapolis MN, Rochester MN, Madison WI, St Louis MO,
Sponsor: Parabilis Medicines, Inc.
Sex: All
Age: 18+
Code: NCT05919264
Phase 1, Phase 2, Recruiting
Active & Responsive
Safety, PK/PD, and Exploratory Efficacy Study of AMT-191 in Classic Fabry Disease
for
Fabry Disease
Location: Minneapolis MN, Chicago IL, Cincinnati OH,
Sponsor: UniQure Biopharma B.V.
Sex: Male
Age: 18 - 65
Code: NCT06270316
Phase 1, Phase 2, Recruiting
Active & Responsive
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
for
Advanced Melanoma
Location: Minneapolis MN, Rochester MN, Westwood KS, St Louis MO,
Sponsor: Immunocore Ltd
Sex: All
Age: 18+
Code: NCT05549297
Phase 3, Recruiting
Active & Responsive
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
for
PIK3CA Mutation, HER2- Negative Breast Cancer,
Location: Minneapolis MN, Sioux Falls SD, Madison WI, Omaha NE,
Sponsor: Relay Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06982521
Phase 3, Recruiting
Active & Responsive
Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]
for
Non-small Cell Lung Cancer, NSCLC
Location: Minneapolis MN, Chicago IL, Ypsilanti MI, Kitchener,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06422143
Phase 3, Recruiting
Active & Responsive
A Study of I-DXd in Combination With Atezolizumab With or Without Carboplatin as First-Line Induction or Maintenance in Subjects With Extensive Stage-Small Cell Lung Cancer (IDeate-Lung03)
for
Extensive Stage-small Cell Lung Cancer
Location: Minneapolis MN, Rochester MN, Milwaukee WI, Chicago IL,
Sponsor: Daiichi Sankyo
Sex: All
Age: 18+
Code: NCT06362252
Phase 1, Phase 2, Recruiting
Active & Responsive
Multicenter ALS Imaging Study
for
Amyotrophic Lateral Sclerosis, ALS
Location: Minneapolis MN, Evanston IL, Gainesville FL
Sponsor: University of Minnesota
Sex: All
Age: 18+
Code: NCT06735014
Recruiting
Active & Responsive
cHAnging the Perceived Pain INtensity in divErSe Populations With Spinal Cord Injury